Clinical Trial Update: Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 study of ridaforolimus in combination with standard chemotherapy for soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Ridaforolimus (ridaforolimus)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: WITHDRAWN